8600 Dubendorf, ch
+44 (161) 249-5400
Myriad Shareholders Vote Overwhelmingly in Favour of Management Resolutions at EGM
1. Mr Erik Hansen was elected as non-executive member of the Board of Directors with 99.86% of the votes represented.
2. The Shareholders' Meeting approved the creation of authorised capital in accordance with Article 3c of the Articles of Incorporation. This agenda item was approved with 99.23% of the votes represented.
Mr. Hansen, a Danish citizen, is a recognised software industry veteran with over 30 years of experience as a senior executive at leading companies, including: Day Software, Interwoven, TIBCO, Siemens Pyramid and Apple, both in Europe and in the United States.
"We are delighted that Erik has joined our Board of Directors. He brings a wealth of sector knowledge to our business and we look forward to him contributing to our future success," said Simon Wilkinson, CEO of Myriad Group. "In addition, with the approval to issue new share capital, we are now well placed to execute against our strategic plans for the business, including the planned acquisition of Synchronica plc."
The Board of Directors of Myriad believes the acquisition of Synchronica would create a strong European-headquartered global competitor, with increased critical mass in expanding world and regional markets. The combined business led by Myriad's management team would be a leader in mobile software technology. The enhanced product portfolio and cross-selling opportunities would strongly position the business to exploit the opportunities presented by the growing global demand for mobile data consumption and deliver enhanced value for shareholders.
For further information regarding our offer to acquire Synchronica please refer to the detailed documents on the Myriad's website www.myriadgroup.com.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.